Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Marketing application filed in Australia for PhotoCure's Metvix PDT

March 16, 2001

Id4 identified as regulator of BRCA1 expression

March 16, 2001

Patient enrollment complete in pivotal phase III trial of Xcytrin

March 15, 2001

Morphochem/Sosei collaboration will optimize anticancer telomerase inhibitor

March 15, 2001

Cumulative neuromuscular toxicity is dose-limiting for LU-79553

March 15, 2001

OSI begins first in series of OSI-774 trials in combination with anticancer agents

March 15, 2001

NIH technology available for licensing: antiprogestins with partial agonist activity

March 15, 2001

Ceramide analogues from Bracco induce apoptosis in cancer cells

March 14, 2001

Second-generation Vitaxin enters phase I evaluation for treatment of solid tumors

March 14, 2001

TranXenoGen licenses novel anticancer protein

March 14, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...